Volgen
Jonathan Kuten
Jonathan Kuten
Onbekend partnerschap
Geverifieerd e-mailadres voor mskcc.org
Titel
Geciteerd door
Geciteerd door
Jaar
Head-to-head comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in staging prostate cancer using histopathology and immunohistochemical analysis as a reference standard
J Kuten, I Fahoum, Z Savin, O Shamni, G Gitstein, D Hershkovitz, ...
Journal of Nuclear Medicine 61 (4), 527-532, 2020
1682020
Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma
J Kuten, C Levine, O Shamni, S Pelles, I Wolf, G Lahat, E Mishani, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-8, 2022
742022
[68Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up?
J Kuten, D Sarid, O Yossepowitch, NJ Mabjeesh, E Even-Sapir
EJNMMI research 9, 1-8, 2019
232019
Brain metastasis of nasopharyngeal carcinoma: a case report and literature review
O Kaidar-Person, J Kuten, F Atrash, S Billan, A Kuten
Case Reports in Medicine 2012, 2012
232012
The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0
J Kuten, S Dekalo, I Mintz, O Yossepowitch, R Mano, E Even-Sapir
EJNMMI research 11, 1-8, 2021
212021
Personalized radiation dosimetry for PRRT—how many scans are really required?
N Freedman, M Sandström, J Kuten, N Shtraus, I Ospovat, A Schlocker, ...
EJNMMI physics 7, 1-15, 2020
212020
68Ga-PSMA PET/CT: does it predict adverse pathology findings at radical prostatectomy?
S Dekalo, J Kuten, NJ Mabjeesh, A Beri, E Even-Sapir, O Yossepowitch
Urologic Oncology: Seminars and Original Investigations 37 (9), 574. e19-574 …, 2019
202019
Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate-and High-Risk Prostate Cancer.
J Kuten, NJ Mabjeesh, H Lerman, C Levine, S Barnes, E Even-Sapir
The Israel Medical Association journal: IMAJ 21 (2), 100-104, 2019
192019
[18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: proof-of-concept study
J Kuten, A Linevitz, H Lerman, N Freedman, M Kestenbaum, T Shiner, ...
Journal of Integrative Neuroscience 19 (3), 489-494, 2020
122020
Preoperative 68Ga-PSMA PET/CT defines a subgroup of high-risk prostate cancer patients with favorable outcomes after radical prostatectomy and lymph node dissection
S Dekalo, J Kuten, I Mintz, I Fahoum, G Gitstein, D Keizman, D Sarid, ...
Prostate Cancer and Prostatic Diseases 24 (3), 910-916, 2021
102021
Anaplastic ganglioglioma in the spinal cord: case report and literature review
J Kuten, O Kaidar-Person, E Vlodavsky, S Postovsky, S Billan, A Kuten, ...
Pediatric Neurosurgery 48 (4), 245-248, 2013
102013
Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement
M Kesler, K Kerzhner, I Druckmann, J Kuten, C Levine, D Sarid, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-9, 2022
92022
Long-term scopolamine treatment and dental caries
E Galili, E Averbuch Zehavi, Y Zadik, T Caspi, L Meltzer, I Merdler, J Kuten, ...
Clinical Oral Investigations 23, 2339-2344, 2019
72019
68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for patients with favorable intermediate-risk prostate cancer
S Dekalo, J Kuten, J Campbell, I Mintz, Y Bar-Yosef, D Keizman, D Sarid, ...
Canadian Urological Association Journal 16 (7), E381, 2022
52022
1: CAS: 528: DC% 2BB3cXhvVOisbjK: Head-to-head comparison of (68) Ga-PSMA-11 with (18) F-PSMA-1007 PET/CT in staging prostate cancer using histopathology and …
J Kuten, I Fahoum, Z Savin, O Shamni, G Gitstein, D Hershkovitz
J Nucl Med, 527-532, 2020
52020
The added value of 18F-FDOPA PET/CT in the work-up of patients with movement disorders
K Khamis, N Giladi, C Levine, M Kesler, J Kuten, H Lerman, E Even-Sapir
Neurographics 9 (5), 344-348, 2019
42019
The role of PSMA PET/CT in imaging prostate cancer
J Kuten, M Kesler, E Even-Sapir
Harefuah 160 (7), 455-461, 2021
32021
68Ga-PSMA-11 PET/CT follow-up of patients with prostate cancer with bone metastases who had reduced bone density after androgen deprivation therapy
M Kesler, I Druckmann, C Levine, J Kuten, O Yossepowitch, E Even-Sapir
Diagnostics 11 (2), 277, 2021
32021
Gastrointestinal stromal tumor of the ampulla of Vater.
E Brauner, J Kuten, O Ben-Ishay, D Hershkovitz, Y Kluger
The Israel Medical Association journal: IMAJ 14 (9), 588-589, 2012
32012
Kansallinen omakuva ja kielteiset tunteet
R Rossi, E Nykänen
22020
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20